# Nitazoxanide for the Treatment of Chronic Diarrhea in HIV Infected Children

> **NCT00055107** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 6 (actual)

## Conditions studied

- HIV Infections
- Cryptosporidiosis

## Interventions

- **DRUG:** Nitazoxanide

## Key facts

- **NCT ID:** NCT00055107
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2006-05
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2021-11-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00055107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00055107, "Nitazoxanide for the Treatment of Chronic Diarrhea in HIV Infected Children". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00055107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*